Fast Track status just doesn't seem to actually make a difference along the path to commercialization. It was granted to Cvac a long time ago, well before the Sept 2013 announcement of the CAN003 trial results.
Accelerated Approval is the real "Fast Track". It allows the drug or treatment to go on sale even before all the trial results are in, as long as safety has been proven (see Olaparib). If they are trying to apply for this, they can't comment on it until the FDA issues an announcement.
I hope it's a possibility but I just don't know.
Fast Track Designation, page-3
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |